Biochemist Pharmacist (USP and UFRJ), MBA in Marketing (COPPEAD) and Finances (IAG-PUC), MD (EMSM-RJ).
Advertising executive, MBA in Management and Finances.
Industrial Pharmacist (UFRJ), with specialization in Pharmaceutical Industrial Technology (UFRJ), in Quality and Productivity, Pharmacology, IP and Regulatory Affairs.
MD, MSc, with specialization in Infectious Disease and Hematology.
Biochemist Pharmacist (UFRJ), Master in Morphologic Sciences.
Industrial Pharmacist (UFRJ), with specialization in Pharmaceutical Industrial Technology (UFRJ) and MBA in Total Quality Management (UFF).
Industrial Pharmacist (UFRJ), with specialization in Pharmaceutical Industrial Technology (UFRJ).
Cell Biologist, with specialization in Immunology (PAHO/WHO), Master in Biochemistry (UFRGS), PhD Morphologic Sciences (UFRJ).
He holds a BA from Harvard College, an MSc from the University of Colorado and an MBA, a Master of Business Economics and a PhD (Management) from the Wharton School of the University of Pennsylvania. Mario Gobbo was Head of Life Sciences at the International Finance Corporation and then at Natixis Bleichroeder Bank. He has over 23 years of banking experience, which spans pharmaceuticals and biotechnology, as well as oil and gas, telecommunications, power and financial institutions.
Dr. Sanberg is a world-renowned stem cell biologist with extensive experience in translating neural therapies from the laboratory to the clinic for neurodegenerative and age-related disorders. Dr. Sanberg is Senior Associate Vice President for Research & Innovation, Distinguished University Professor, Director of the Center of Excellence for Aging and Brain Repair, and Vice Chairman of the Department of Neurosurgery in the College of Medicine, at the University of South Florida. He also has significant experience with numerous biotech start-up companies. Dr. Sanberg is currently chairman and founder of Saneron CCEL Therapeutics, Inc. (a USF spin-out company based in Tampa), which is involved in cell therapy for degenerative disorders.
Jack Salvo is an expert in Technical and Regulatory Affairs. He is a member of the board of CellPraxis® USA. Mr. Salvo is the Vice-President of Business Development for Interchem Corporation, one of the largest sales and regulatory agents of active pharmaceutical ingredients in the USA.
M.D., M.Sc, Ph.D. He received his undergraduate and medical degree from Rio de Janeiro University (1985-1990) followed by residency training in Dermatology at Federal University of Rio de Janeiro (1991-1993). Received his MSc (1995) and PhD (1998) in Dermatology, specializing in viral infections. Dr. Lupi is the president of Brazilian Society of Dermatology.